| MTX (n = 8) | MTX + infliximab (n = 15) | ||
---|---|---|---|---|
 | first visit | seventh visit | first visit | seventh visit |
DAS 44 | 5.2 ± 0.4 | 4.4 ± 0.4* | 5.8 ± 0.5 | 3.9 ± 0.5* |
RF (IU) | 210.1 ± 117.9 | 146.4 ± 80.4 | 396.2 ± 178.4 | 257.3 ± 142.8* |
CRP (mg/dl) | 0.8 ± 0.3 | 0.6 ± 0.2 | 1.8 ± 0.5 | 1.1 ± 0.3 |
ESR (mm/hour) | 36.9 ± 5.4 | 31.9 ± 5.0 | 60.2 ± 8.1 | 44.2 ± 5.5* |
SJC | 19.6 ± 4.6 | 14.0 ± 3.0 | 21.9 ± 3.1 | 11.6 ± 2.4* |
TJC | 25.8 ± 4.9 | 16.0 ± 4.3* | 27.0 ± 4.5 | 12.1 ± 3.4* |